Uterine fibroids are benign monoclonal neoplasms of the myometrium, representing the
most common tumors in women worldwide. To date, no long-term or noninvasive treatment …

Fibroepithelial lesions of the breast comprise a morphologically and biologically
heterogeneous group of biphasic tumors with epithelial and stromal components that …

Fibroepithelial lesions of the breast, comprising the fibroadenoma and phyllodes tumour, are
a unique group of neoplasms that share histological characteristics but possess different …

Distinguishing low-grade phyllodes tumor from fibroadenoma is practically challenging due
to their overlapping histologic features. However, the final interpretation is essential to …

Malignant phyllodes tumors of the breast are poorly understood rare neoplasms with
potential for aggressive behavior. Few efficacious treatment options exist for progressed or …

Breast fibroepithelial lesions are biphasic tumors which comprise the common benign
fibroadenomas (FAs) and the rarer phyllodes tumors (PTs). This study analyzed 262 (42%) …

Fibroepithelial lesions (FELs) are a heterogeneous group of tumours comprising
fibroadenomas (FAs) and phyllodes tumours (PTs). Here we used a 16‐gene panel that was …

Triple-negative breast cancer (TNBC) presented as high heterogeneous immunogenicity
that lacks useful clinical signatures to risk-stratify immune-benefit subtypes. We …

Fibroadenomas of the breast are benign fibroepithelial tumours most frequently encountered
in women of reproductive age, although they may be diagnosed at any age. The …

Background: MED12 and TERT promoter mutations have been shown to be the most
common somatic mutations in phyllodes tumours (PTs). The aims of this study were to …